SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $15.55 million. The enterprise value is $6.53 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 4.00 million shares outstanding. The number of shares has increased by 442.80% in one year.
| Current Share Class | 4.00M |
| Shares Outstanding | 4.00M |
| Shares Change (YoY) | +442.80% |
| Shares Change (QoQ) | +8.19% |
| Owned by Insiders (%) | 1.05% |
| Owned by Institutions (%) | 3.30% |
| Float | 3.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.83 |
| Forward PS | 10.75 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.73 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -459.85 |
Financial Efficiency
Return on equity (ROE) is -302.01% and return on invested capital (ROIC) is -174.31%.
| Return on Equity (ROE) | -302.01% |
| Return on Assets (ROA) | -79.24% |
| Return on Invested Capital (ROIC) | -174.31% |
| Return on Capital Employed (ROCE) | -163.44% |
| Weighted Average Cost of Capital (WACC) | -1.20% |
| Revenue Per Employee | $84,471 |
| Profits Per Employee | -$699,941 |
| Employee Count | 17 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.96 |
Taxes
In the past 12 months, ICU has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.63% in the last 52 weeks. The beta is -1.02, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.02 |
| 52-Week Price Change | -68.63% |
| 50-Day Moving Average | 3.71 |
| 200-Day Moving Average | 4.61 |
| Relative Strength Index (RSI) | 45.26 |
| Average Volume (20 Days) | 76,300 |
Short Selling Information
The latest short interest is 217,777, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 217,777 |
| Short Previous Month | 159,384 |
| Short % of Shares Out | 5.45% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 0.99 |
Income Statement
In the last 12 months, ICU had revenue of $1.44 million and -$11.90 million in losses. Loss per share was -$4.19.
| Revenue | 1.44M |
| Gross Profit | 1.34M |
| Operating Income | -11.96M |
| Pretax Income | -11.90M |
| Net Income | -11.90M |
| EBITDA | n/a |
| EBIT | -11.96M |
| Loss Per Share | -$4.19 |
Full Income StatementBalance Sheet
The company has $9.35 million in cash and $331,000 in debt, with a net cash position of $9.02 million or $2.26 per share.
| Cash & Cash Equivalents | 9.35M |
| Total Debt | 331,000 |
| Net Cash | 9.02M |
| Net Cash Per Share | $2.26 |
| Equity (Book Value) | 7.32M |
| Book Value Per Share | 1.83 |
| Working Capital | 6.82M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.71M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -45,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 93.11% |
| Operating Margin | -832.59% |
| Pretax Margin | -828.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -442.80% |
| Shareholder Yield | -442.80% |
| Earnings Yield | -76.53% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ICU is $10.00, which is 157.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 157.07% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
